Multiple myeloma mortality in Latin America: Heterogeneous patterns and challenges in cross-country comparisons
Cancer Epidemiology · 2026-08 · 103 · 103103
DOI: 10.1016/j.canep.2026.103103 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Epidemiology, 2026-08. Verfasst von Bryan Valcarcel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit nennt 25 Literaturangaben. Gefördert von: American Society of Hematology.
Abstract (Originalsprache)
INTRODUCTION: Differences in death certification practices may affect cross-country comparisons of multiple myeloma (MM) mortality estimates. In Latin America, where access to transplantation and novel therapies remains limited, MM mortality patterns have not consistently aligned with expected differences. We describe MM mortality rates across Latin American countries and compare them to those of Hispanic individuals in the United States (US). METHODS: In this population-based study, we analyzed mortality data from 15 Latin American countries (World Health Organization Mortality Database) and the US (National Center for Health Statistics data). MM deaths among adults (≥20 years) during 2008-2019 were examined using US Hispanic individuals as reference. RESULTS: The highest mortality (per 100,000 persons) in Latin American countries was observed in Chile (4.12), Uruguay (4.11), and Costa Rica (3.57). Mortality for US Hispanic individuals was 3.8. Most countries exhibited lower or comparable mortality rate ratios (MMRs) relative to US Hispanic individuals. Stratified analyses by sex showed similar findings. However, this pattern was not consistent across age groups. Young adults (20-59 years) generally experienced higher mortality, particularly in Cuba (MRR=2.04, 95% CI=1.88-2.21; Pheterogeneity
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Hospital de Clínicas, Montevideo, Uruguay; Hospital Británico, Montevideo, Uruguay.
- Hematology Unit, Hospital del Salvador, Santiago de Chile, Chile; Advanced clinical research Center (CICA-Oriente), Universidad de Chile, Santiago de Chile, Chile.
- Hospital Central Instituto de Previsión Social, Asunción, Paraguay.
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: LEMalpica@mdanderson.org.
Förderung
- American Society of Hematology
Zitieren
APA
Valcarcel, B., Riva, E., Peña, C., von Glasenapp, A., Leautaud, V., Malpica, L., & Hildebrandt, M. A. T. (2026). Multiple myeloma mortality in Latin America: Heterogeneous patterns and challenges in cross-country comparisons. Cancer Epidemiology, 103, 103103. https://doi.org/10.1016/j.canep.2026.103103
Vancouver
Valcarcel B, Riva E, Peña C, von Glasenapp A, Leautaud V, Malpica L, et al. Multiple myeloma mortality in Latin America: Heterogeneous patterns and challenges in cross-country comparisons. Cancer Epidemiology. 2026;103:103103. doi:10.1016/j.canep.2026.103103
BibTeX
@article{Valcarcel2026,
author = {Valcarcel, Bryan and Riva, Eloísa and Peña, Camila and von Glasenapp, Alana and Leautaud, Veronica and Malpica, Luis and Hildebrandt, Michelle A T},
title = {Multiple myeloma mortality in Latin America: Heterogeneous patterns and challenges in cross-country comparisons},
journal = {Cancer Epidemiology},
year = {2026},
volume = {103},
pages = {103103},
doi = {10.1016/j.canep.2026.103103}
}
EUVIMED